Cite
Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism
MLA
Pei, Yingzi, et al. “Rosuvastatin Attenuates Monocrotaline-Induced Pulmonary Hypertension via Regulation of Akt/ENOS Signaling and Asymmetric Dimethylarginine Metabolism.” European Journal of Pharmacology, vol. 666, no. 1–3, Sept. 2011, pp. 165–72. EBSCOhost, https://doi.org/10.1016/j.ejphar.2011.05.035.
APA
Pei, Y., Ma, P., Wang, X., Zhang, W., Zhang, X., Zheng, P., Yan, L., Xu, Q., & Dai, G. (2011). Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism. European Journal of Pharmacology, 666(1–3), 165–172. https://doi.org/10.1016/j.ejphar.2011.05.035
Chicago
Pei, Yingzi, Ping Ma, Xin Wang, Wei Zhang, Xia Zhang, Ping Zheng, Lin Yan, Qingbin Xu, and Guidong Dai. 2011. “Rosuvastatin Attenuates Monocrotaline-Induced Pulmonary Hypertension via Regulation of Akt/ENOS Signaling and Asymmetric Dimethylarginine Metabolism.” European Journal of Pharmacology 666 (1–3): 165–72. doi:10.1016/j.ejphar.2011.05.035.